HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Androgen therapy during myeloblastic leukemia remission induced by two drug combinations.

AuthorsS Pavlovsky, C Scaglione, M Eppinger-Helft, F S Muriel, A Macchi, G Garay, F Cavagnaro, V Birman, J Dupont, A Suarez, M O Dragosky, C A Barros
JournalMedicina (Medicina (B Aires)) Vol. 41 Issue 1 Pg. 11-8 ( 1981) ISSN: 0025-7680 [Print] Argentina
PMID7022104 (Publication Type: Clinical Trial, Journal Article)
Chemical References
  • Antineoplastic Agents
  • Cytarabine
  • Stanozolol
  • Vincristine
  • Prednisone
  • Daunorubicin
Topics
  • Adolescent
  • Adult
  • Antineoplastic Agents (administration & dosage)
  • Child
  • Clinical Trials as Topic
  • Cytarabine (therapeutic use)
  • Daunorubicin (therapeutic use)
  • Drug Therapy, Combination
  • Humans
  • Leukemia, Myeloid, Acute (drug therapy)
  • Middle Aged
  • Prednisone (therapeutic use)
  • Stanozolol (therapeutic use)
  • Vincristine (therapeutic use)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: